Xeris Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsXeris Pharmaceuticals

Xeris Pharmaceuticals(XERS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Keveyis	Dichlorphenamide	1982-01-01		Glaucoma

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

,

,

hepatic insufficiency

,

chronic kidney failure

,

renal insufficiency

,

,

chronic renal insufficiency

,

,

binge-eating disorder

,

type 1 diabetes mellitus

,

,

glucose metabolism disorders

,

endocrine system diseases

,

,

non-alcoholic fatty liver disease

,

,

nutrition disorders

,

left ventricular dysfunction

,

,

obstructive sleep apnea

,

sleep apnea syndromes

,

,

prediabetic state

,

,

,

,

ulcerative colitis

,

,

type 2 diabetes mellitus

,

,

diabetes mellitus

,

,

metabolic diseases

,

metabolic syndrome

,

,

psoriatic arthritis

,

coronary artery disease

,

,

myocardial ischemia

,

atherosclerosis

,

knee osteoarthritis

,

,

,

,

pseudotumor cerebri

,

,

thyroid neoplasms

,

neuroendocrine carcinoma

,

papillary thyroid cancer

,

thyroid diseases

,

diabetic nephropathies

,

healthy volunteers/patients

,

glycemic control

,

,

,

,

colorectal neoplasms

,

colonic neoplasms

,

rectal neoplasms

,

head and neck neoplasms

,

squamous cell carcinoma of head and neck

,

hyperinsulinism

,

,

neuroendocrine tumors

,

neoplasm metastasis

,

carcinoid tumor

,

islet cell carcinoma

,

,

chronic renal insufficiency

,

glucose metabolism disorders

,

endocrine system diseases

,

,

cardiovascular diseases

,

,

chronic obstructive pulmonary disease

,

,

,

,

,

,

kidney diseases

,

type 2 diabetes mellitus

,

diabetes mellitus

,

type 1 diabetes mellitus

,

insulin resistance

,

,

metabolic diseases

,

,

metabolic syndrome

,

gestational diabetes

,

myocardial infarction

,

inferior wall myocardial infarction

,

psychotic disorders

,

prediabetic state

,

disease progression

,

,

patient participation

,

diabetic neuropathies

,

glucose intolerance

type 1 diabetes mellitus

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use